Increase in CIP2A expression is associated with doxorubicin resistance

FEBS Letters

Volumn 585, Issue 5, 2011, Pages 755-760

  Choi, Yeon A ^a   Park, Jeong Su ^a   Park, Mi Young ^a   Oh, Ki Sook ^a   Lee, Myung Sok ^a   Lim, Jong Seok ^a   Kim, Keun Il ^a   Kim, Kun Yong ^a   Kwon, Junhye ^a   Yoon, Do Young ^b   Moon, Eun Yi ^c   Yang, Young ^a  

^a Sookmyung Women's University   (South Korea)

^b Konkuk University   (South Korea)

^c Sejong University   (South Korea)

Author keywords

Akt; Cancerous inhibitor of PP2A; Doxorubicin; p53

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; PACLITAXEL; PROTEIN KINASE B; PROTEIN P53;

ARTICLE; CANCER CELL; CANCER RESISTANCE; CANCEROUS INHIBITOR OF PROTEIN PHOSPHATASE 2A GENE; CELL STRAIN HCT116; CELL STRAIN MCF 7; CHEMOSENSITIVITY; CONTROLLED STUDY; DOWN REGULATION; GENE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

AUTOANTIGENS; BREAST NEOPLASMS; CELL PROLIFERATION; DOWN-REGULATION; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HCT116 CELLS; HUMANS; MEMBRANE PROTEINS; MUTANT PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 79952311883     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2011.01.018     Document Type: Article

References (27)

1. C. Come CIP2A is associated with human breast cancer aggressivity Clin. Cancer Res. 15 2009 5092 5100
2. M.R. Junttila CIP2A inhibits PP2A in human malignancies Cell 130 2007 51 62 (Pubitemid 47039258)
3. A. Khanna MYC-dependent regulation and prognostic role of CIP2A in gastric cancer J. Natl. Cancer Inst. 101 2009 793 805
4. W. Li, Z. Ge, C. Liu, Z. Liu, M. Bjorkholm, J. Jia, and D. Xu CIP2A is overexpressed in gastric cancer and its depletion leads to impaired clonogenicity, senescence, or differentiation of tumor cells Clin. Cancer Res. 14 2008 3722 3728
5. B.J. Pulverer, C. Fisher, K. Vousden, T. Littlewood, G. Evan, and J.R. Woodgett Site-specific modulation of c-Myc cotransformation by residues phosphorylated in vivo Oncogene 9 1994 59 70 (Pubitemid 24020934)
6. R. Sears, F. Nuckolls, E. Haura, Y. Taya, K. Tamai, and J.R. Nevins Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability Genes Dev. 14 2000 2501 2514
7. M.A. Gregory, Y. Qi, and S.R. Hann Phosphorylation by glycogen synthase kinase-3 controls c-myc proteolysis and subnuclear localization J. Biol. Chem. 278 2003 51606 51612 (Pubitemid 38020405)
8. E. Yeh A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells Nat. Cell Biol. 6 2004 308 318 (Pubitemid 38584820)
9. M.R. Junttila, and J. Westermarck Mechanisms of MYC stabilization in human malignancies Cell Cycle 7 2008 592 596 (Pubitemid 351498996)
10. S. Fulda, H. Sieverts, C. Friesen, I. Herr, and K.M. Debatin The CD95 (APO-1/Fas) system mediates drug-induced apoptosis in neuroblastoma cells Cancer Res. 57 1997 3823 3829 (Pubitemid 27381230)
11. S. Fulda, G. Strauss, E. Meyer, and K.M. Debatin Functional CD95 ligand and CD95 death-inducing signaling complex in activation-induced cell death and doxorubicin-induced apoptosis in leukemic T cells Blood 95 2000 301 308 (Pubitemid 30017256)
12. T. Aas, A.L. Borresen, S. Geisler, B. Smith-Sorensen, H. Johnsen, J.E. Varhaug, L.A. Akslen, and P.E. Lonning Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients Nat. Med. 2 1996 811 814 (Pubitemid 26225099)
13. F. Vikhanskaya, M. D'Incalci, and M. Broggini Decreased cytotoxic effects of doxorubicin in a human ovarian cancer-cell line expressing wild-type p53 and WAF1/CIP1 genes Int. J. Cancer 61 1995 397 401
14. T.R. Dunkern, I. Wedemeyer, M. Baumgartner, G. Fritz, and B. Kaina Resistance of p53 knockout cells to doxorubicin is related to reduced formation of DNA strand breaks rather than impaired apoptotic signaling DNA Repair (Amst.) 2 2003 49 60 (Pubitemid 35435438)
15. L. Vrba, D.J. Junk, P. Novak, and B.W. Futscher P53 induces distinct epigenetic states at its direct target promoters BMC Genomics 9 2008 486
16. J.S. Roe, H. Kim, S.M. Lee, S.T. Kim, E.J. Cho, and H.D. Youn P53 stabilization and transactivation by a von Hippel-Lindau protein Mol. Cell 22 2006 395 405
17. S.R. Datta, H. Dudek, X. Tao, S. Masters, H. Fu, Y. Gotoh, and M.E. Greenberg Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery Cell 91 1997 231 241 (Pubitemid 27456390)
18. M.H. Cardone, N. Roy, H.R. Stennicke, G.S. Salvesen, T.F. Franke, E. Stanbridge, S. Frisch, and J.C. Reed Regulation of cell death protease caspase-9 by phosphorylation Science 282 1998 1318 1321 (Pubitemid 28524494)
19. A.M. Tari, A. Mehta, and G. Lopez-Berestein Modulation of Akt activity by doxorubicin in breast cancer cells J. Chemother. 13 2001 334 336 (Pubitemid 32575146)
20. G. Batist, A. Tulpule, B.K. Sinha, A.G. Katki, C.E. Myers, and K.H. Cowan Overexpression of a novel anionic glutathione transferase in multidrug-resistant human breast cancer cells J. Biol. Chem. 261 1986 15544 15549 (Pubitemid 17208781)
21. S. Somfai-Relle, K. Suzukake, B.P. Vistica, and D.T. Vistica Reduction in cellular glutathione by buthionine sulfoximine and sensitization of murine tumor cells resistant to L-phenylalanine mustard Biochem. Pharmacol. 33 1984 485 490 (Pubitemid 14163173)
22. E.G. Mimnaugh, L. Dusre, J. Atwell, and C.E. Myers Differential oxygen radical susceptibility of adriamycin-sensitive and -resistant MCF-7 human breast tumor cells Cancer Res. 49 1989 8 15 (Pubitemid 19024400)
23. J. Westermarck, and W.C. Hahn Multiple pathways regulated by the tumor suppressor PP2A in transformation Trends Mol. Med. 14 2008 152 160
24. X. Li, Y. Lu, K. Liang, B. Liu, and Z. Fan Differential responses to doxorubicin-induced phosphorylation and activation of Akt in human breast cancer cells Breast Cancer Res. 7 2005 R589 R597
25. C. Knuefermann HER2/PI-3K/Akt activation leads to a multidrug resistance in human breast adenocarcinoma cells Oncogene 22 2003 3205 3212 (Pubitemid 36712932)
26. K. Liang, Y. Lu, W. Jin, K.K. Ang, L. Milas, and Z. Fan Sensitization of breast cancer cells to radiation by trastuzumab Mol. Cancer Ther. 2 2003 1113 1120
27. R. Suvasini, and K. Somasundaram Essential role of PI3-kinase pathway in p53-mediated transcription: implications in cancer chemotherapy Oncogene 29 2010 3605 3618